A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Chronic Thromboembolic Pulmonary Hypertension
In brief
Selexipag is available in many countries for the treatment of pulmonary arterial hypertension (PAH). Due to the similarities between PAH and chronic thromboembolic pulmonary hypertension (CTEPH) and the observed efficacy of other PAH medicines in CTEPH, it is believed that selexipag could benefit to patients with CTEPH. This study aims to assess the efficacy and safety of selexipag in participants with inoperable or persistent/recurrent CTEPH.
Key facts
- Study ID
- NCT03689244
- Run by
- Actelion
- People needed
- 128
- Starts
- 2019-01-23
- Expected to finish
- 2022-06-07
- Last updated by the study team
- 2024-06-21
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Southern California, Keck School of Medicine — Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
- Colorado Springs Pulmonary Consultants — Colorado Springs, Colorado, United States
- South Denver Cardiology Associates PC — Littleton, Colorado, United States
- Mayo Clinic in Florida — Jacksonville, Florida, United States
- Piedmont Healthcare — Atlanta, Georgia, United States
- Emory University — Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine — Chicago, Illinois, United States
- University of Chicago Hospitals - Chicago — Chicago, Illinois, United States
- Advocate Christ Medical Center — Oak Lawn, Illinois, United States
- University of Maryland — Baltimore, Maryland, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Sparrow Clinical Research Institute — Lansing, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University in St. Louis — St Louis, Missouri, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- St. Mary's Cardiology — Reno, Nevada, United States
- University of New Mexico Clinical & Translational Science Center — Albuquerque, New Mexico, United States
- Duke University Medical Center — Durham, North Carolina, United States
- University of Cincinnati Medical Center — Cincinnati, Ohio, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Temple University Hospital — Philadelphia, Pennsylvania, United States
- Allegheny — Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- University of California San Diego Medical Center — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.